News
UCSF Patient Home Health Care. Photo by Elizabeth Fall

Two New Guides Released to Help Older Patients with Cancer

While cancer diagnoses have been increasing among younger adults, cancer is still more common in older adults, particularly those 60 years and older. As the population ages, the number of cancer cases is expected to rise, underscoring the need to tailor treatment strategies for older adults. Today
From left toright: Kevan Shokat, PhD, winner of the Gamechanger Award; Joseph DeRisi, PhD, winner of the Best Startup Award; Susan Lynch, PhD, winner of the Disruptive Research Award; and Steven Hauser, MD, winner of the Distinguished Lifetime Achievement Award.

UCSF Wins Big, From Gamechangers to Startups to Life Achievement

Four UC San Francisco professors received UC Regents Innovation Awards on Sept. 16, celebrating their accomplishments transforming multiple sclerosis care, advancing faster disease diagnostics, pioneering microbiome-based disease prevention, and developing new approaches to precision cancer
Ryan Grant, RN, a clinical nurse in the Pediatric Intensive Care Nursery, checks on his 15-day-old patient at UCSF Benioff Children’s Hospital, San Francisco. Photo by Susan Merrell

UCSF Benioff Children’s Hospitals Earn Strongest US News Rankings

UCSF Benioff Children’s Hospitals achieved its strongest showing to date in the 2026-27 U.S. News & World Report Best Children’s Hospitals list, tying as the best among children’s hospitals in Northern California. All specialties assessed were nationally recognized for the ninth consecutive year
Low Grade Glioma

FDA Approves PET Imaging Agent for Brain Cancer Based on UCSF Data

UC San Francisco study data was instrumental in today’s approval by the Food and Drug Administration (FDA) of a PET imaging agent that helps physicians evaluate gliomas, a form of brain cancer. The approval of floretyrosine F 18 (18F-FET) was supported by prospective clinical trial data generated at
Fluorescent microscopy image of a fibrotic breast tumor, with DNA damage highlighted in pink

This is How Dense Breast Tissue May Lead to Cancer

Breast cancer often grows in tissue that is unusually dense. That’s why clinicians flag women with this kind of breast tissue for follow-up after a mammogram. A UC San Francisco study has uncovered a mechanism that could help explain how this dense environment promotes breast cancer. Dense tissue
Dr. Andrew Ko in clinic; image of two Daraxonrasib pills

New Drug With UCSF Roots Has Revolutionized Pancreatic Cancer Care

UC San Francisco researchers took on one of science’s lost causes. Today, their work has finally ushered in hope for pancreatic cancer — one of medicine’s most devastating diseases. The Food and Drug Administration (FDA) recently approved daraxonrasib, the first drug shown to substantially extend
A pharmacy technician wearing blue latex glove and a surgical mask prepares a dose of the Moderna COVID-19 vaccine.

Why Novel Cancer Vaccine Tested at UCSF Marks New Treatment Era

A personalized mRNA vaccine tested at UC San Francisco has become the first to successfully prevent the return and spread of cancer in late-stage clinical trials. The results could signal a new era of vaccines to treat a range of cancers, says UCSF Professor of Medicine Adil Daud, MD, who led the